Reprint of: Does minimally invasive parathyroidectomy improve cosmetic outcome? von Truran, P, Thompson, E, Nightingale, H, Bliss, R.D, Aspinall, S.R, Lennard, T.W.J

Volltext

Does minimally invasive parathyroidectomy improve cosmetic outcome? von Truran, P, Thompson, E, Nightingale, H, Bliss, R.D, Aspinall, S.R, Lennard, T.W.J

Volltext

Primary squamous cell carcinoma of the thyroid gland: A case report and role of radiotherapy von Hadi, I.Ab, Bliss, R.D, Lennard, T.W.J, Welch, A.R

Volltext

Metachronous testicular teratoma, testicular seminoma and papillary thyroid carcinoma occurring in a single individual: a report of two unrelated cases: Bilateral testicular and th... von SYED, A.A., JONES, N.A.G., BLISS, R.D., ROBERTS, J.T., MALLICK, U.K., JOHNSON, S.J., DOUGLAS, S.F., PERROS, P., QUINTON, R.

Volltext

Metachronous testicular teratoma, testicular seminoma and papillary thyroid carcinoma occurring in a single individual: a report of two unrelated cases von SYED, A.A., JONES, N.A.G., BLISS, R.D., ROBERTS, J.T., MALLICK, U.K., JOHNSON, S.J., DOUGLAS, S.F., PERROS, P., QUINTON, R.

Volltext

ES08
DIAGNOSTIC AND THERAPEUTIC STRATEGIES OF ADRENOCORTICAL CARCINOMA‐A 3‐INSTITUTION EXPERIENCE von Imisairi, A. H., Hisham, A.N., Lennard, T.W.J., Bliss, R.D., Harrison, B.J., Perini, M.

Volltext

ES08DIAGNOSTIC AND THERAPEUTIC STRATEGIES OF ADRENOCORTICAL CARCINOMA-A 3-INSTITUTION EXPERIENCE von Imisairi, A. H., Hisham, A.N., Lennard, T.W.J., Bliss, R.D., Harrison, B.J., Perini, M.

Volltext

Effect of menstrual phase on surgical treatment of breast cancer von Fentiman, IanS, Gregory, W.M., Richards, M.A., McCulloch, Peter, Choy, Alfred, Minckwitz, Guntervon, Grischke, Eva-Maria, Kaufmann, Manfred, Bliss, R.D., Kirby, J.A., Browell, D.A., Lennard, T.W.J., Badwe, R.A., Hawaldar, R.W.

Volltext

Serum adrenal androgens in women with primary operable breast cancer and their relationship with age and body mass index von Aspinall, S.R, Cook, D.B, Shenton, B.K, Griffiths, A.B, Griffith, C.D.M, Bliss, R.D, Lennard, T.W.J

Volltext

Insulinoma: a review of current management von Bliss, R.D., Carter, P.B., Lennard, T.W.J.

Volltext

Inhibition of endothelial adhesion and invasion by breast carcinoma cells may contribute towards the anti-metastatic effects of tamoxifen von Bliss, R.D., Kirby, J.A., Browell, D.A., Lennard, T.W.J.

Volltext

TREATMENT OF COOLING TOWER WATER TO DESTROY LEGIONNAIRE'S BACTERIA von WILLIAM R.D. BLISS

Volltext bestellen

Changes in plasmalemma organization in cowpea radicle during imbibition in water and NaCl solutions von Bliss, R.D, Platt-Aloia, K.A, Thomson, W.W

Volltext

Plasma ESR1 Mutations and the Treatment of Estrogen Receptor-Positive Advanced Breast Cancer von Fribbens, Charlotte, O'Leary, Ben, Kilburn, Lucy, Hrebien, Sarah, Garcia-Murillas, Isaac, Beaney, Matthew, Cristofanilli, Massimo, Andre, Fabrice, Loi, Sherene, Loibl, Sibylle, Jiang, John, Bartlett, Cynthia Huang, Koehler, Maria, Dowsett, Mitch, Bliss, Judith M, Johnston, Stephen R D, Turner, Nicholas C

Volltext

ESR1 Mutations and Overall Survival on Fulvestrant versus Exemestane in Advanced Hormone Receptor-Positive Breast Cancer: A Combined Analysis of the Phase III SoFEA and EFECT Trial... von Turner, Nicholas C, Swift, Claire, Kilburn, Lucy, Fribbens, Charlotte, Beaney, Matthew, Garcia-Murillas, Isaac, Budzar, Aman U, Robertson, John F R, Gradishar, William, Piccart, Martine, Schiavon, Gaia, Bliss, Judith M, Dowsett, Mitch, Johnston, Stephen R D, Chia, Stephen K

Volltext

Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive lo... von Johnston, Stephen RD, Prof, Kilburn, Lucy S, MSc, Ellis, Paul, Prof, Dodwell, David, Prof, Cameron, David, Prof, Hayward, Larry, MD, Im, Young-Hyuck, MD, Braybrooke, Jeremy P, MD, Brunt, A Murray, MD, Cheung, Kwok-Leung, MD, Jyothirmayi, Rema, MD, Robinson, Anne, MD, Wardley, Andrew M, MD, Wheatley, Duncan, MD, Howell, Anthony, Prof, Coombes, Gill, RGN, Sergenson, Nicole, BSc, Sin, Hui-Jung, BSc, Folkerd, Elizabeth, PhD, Dowsett, Mitch, Prof, Bliss, Judith M, Prof

Volltext

Extreme chromosomal instability forecasts improved outcome in ER-negative breast cancer: a prospective validation cohort study from the TACT trial von Jamal-Hanjani, M., A'Hern, R., Birkbak, N.J., Gorman, P., Grönroos, E., Ngang, S., Nicola, P., Rahman, L., Thanopoulou, E., Kelly, G., Ellis, P., Barrett-Lee, P., Johnston, S.R.D., Bliss, J., Roylance, R., Swanton, C.

Volltext

VP6-2022: Adjuvant pertuzumab and trastuzumab in patients with early HER-2 positive breast cancer in APHINITY: 8.4 years' follow-up von Loibl, S., Jassem, J., Sonnenblick, A., Parlier, D., Winer, E., Bergh, J., Gelber, R.D., Restuccia, E., Im, Y-H., Huang, C., Dalenc, F., Calvo, I., Procter, M., Caballero, C., Clark, E., Gomez Moreno, H.L., Bliss, J., Viale, G., Bines, J., Piccart, M.

Volltext

Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039) von Leary, Alexandra, Evans, Abigail, Johnston, Stephen R D, A'Hern, Roger, Bliss, Judith M, Sahoo, Rashmita, Detre, Simone, Haynes, Benjamin P, Hills, Margaret, Harper-Wynne, Catherine, Bundred, Nigel, Coombes, Gill, Smith, Ian, Dowsett, Mitch

Volltext

99P Analysis of ctDNA in advanced breast cancer reveals polyclonal disease associated with adverse outcome von Kingston, B., Cutts, R., Beaney, M., Walsh-Crestani, G., Hrebien, S., Kilburn, L., Kernaghan, S., Moretti, L., Wilkinson, K., MacPherson, I., Baird, R.D., Roylance, R., Reis-Filho, J.S., Hubank, M., Faull, I., Banks, K., Garcia-Murillas, I., Bliss, J., Ring, A., Turner, N.

Volltext